ICI 174,864

CAS No. 89352-67-0

ICI 174,864( —— )

Catalog No. M30662 CAS No. 89352-67-0

Selective δ opioid antagonist. Exhibits partial agonist in vitro activity at δ receptors at high concentrations.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 387 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    ICI 174,864
  • Note
    Research use only, not for human use.
  • Brief Description
    Selective δ opioid antagonist. Exhibits partial agonist in vitro activity at δ receptors at high concentrations.
  • Description
    Selective δ opioid antagonist. Exhibits partial agonist in vitro activity at δ receptors at high concentrations.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    Opioid Receptor
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    89352-67-0
  • Formula Weight
    691.87
  • Molecular Formula
    C38H53N5O7
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:69.19 mg/mL;water:1 mg/ml
  • SMILES
    CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C(C)(C)NC(=O)C(C)(C)NC(=O)[C@H](CC1=CC=C(O)C=C1)N(CC=C)CC=C)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Cohen et al (1996) Opioid agonist activity of ICI 174864 and its carboxypeptidase degradation product, LY281217. J.Pharmacol.Exp.Ther. 238 769 PMID:
molnova catalog
related products
  • [Leu5]-Enkephalin TF...

    [Leu5]-Enkephalin?is the most potent δ-receptor ago.

  • ADL5859

    ADL5859 is a potent, selective, orally bioavailable full agonist of δ opioid receptor with Ki of 0.84 nM and EC50 of 20 nM.

  • Hemorphin-7

    Hemorphin-7 binds to the angiotensin IV receptor, triggering multiple effects including cellular proliferation and memory enhancement. Hemorphins are endogenous peptides belonging to the family of atypical opioid peptides released from hydrolyzed hemoglobin. Hemorphin-7 is investigated as a potential biomarker for breast cancer.